Search for other papers by Jan W Eriksson in
Google Scholar
PubMed
Search for other papers by Reem A Emad in
Google Scholar
PubMed
Search for other papers by Martin H Lundqvist in
Google Scholar
PubMed
Search for other papers by Niclas Abrahamsson in
Google Scholar
PubMed
Search for other papers by Maria C Kjellsson in
Google Scholar
PubMed
Introduction Development of type 2 diabetes has been perceived as a process that involves progressive insulin resistance in muscles, adipose tissue, and liver and a gradual failure of pancreatic beta cells to secrete sufficient amounts of
Search for other papers by Li Li in
Google Scholar
PubMed
Search for other papers by Qifa Song in
Google Scholar
PubMed
Search for other papers by Xi Yang in
Google Scholar
PubMed
Introduction In the past 40 years, a dramatic increase in the overweight and obese population has been seen globally. The potential adverse effects of obesity include insulin resistance and possible insufficient insulin secretion due to the
Search for other papers by Yansu Wang in
Google Scholar
PubMed
Search for other papers by Yun Shen in
Google Scholar
PubMed
Search for other papers by Tingting Hu in
Google Scholar
PubMed
Search for other papers by Yufei Wang in
Google Scholar
PubMed
Search for other papers by Xiaojing Ma in
Google Scholar
PubMed
Search for other papers by Haoyong Yu in
Google Scholar
PubMed
Search for other papers by Yuqian Bao in
Google Scholar
PubMed
. Thus, the purpose of this study was to investigate the association between serum clusterin levels and NAFLD in the Chinese population. In addition, due to the tight relationship between insulin resistance and clusterin ( 20 ), a mediation analysis would
Search for other papers by Karim Gariani in
Google Scholar
PubMed
Diabetes Center, Faculty of Medicine, University of Geneva, Geneva, Switzerland
Search for other papers by François R Jornayvaz in
Google Scholar
PubMed
risk factors to develop NAFLD and NASH are the presence of insulin resistance and obesity. However, NAFLD and NASH are associated with other extrahepatic manifestations, adding to the burden of disease. These manifestations notably include obstructive
Search for other papers by Yumei Zhai in
Google Scholar
PubMed
Search for other papers by Haiming Fu in
Google Scholar
PubMed
Search for other papers by Yu Li in
Google Scholar
PubMed
Search for other papers by Siyuan Li in
Google Scholar
PubMed
Search for other papers by Wenchen Zhang in
Google Scholar
PubMed
Search for other papers by Jianwei Yue in
Google Scholar
PubMed
Search for other papers by Zichao Wang in
Google Scholar
PubMed
crucial to mitigate associated disabilities and fatalities ( 5 ). Insulin resistance (IR) is a central factor in cardiovascular diseases ( 6 ). In hypertensive patients, IR not only exacerbates hypertension but also contributes to hypertension
Search for other papers by Nicolás Crisosto in
Google Scholar
PubMed
Search for other papers by Bárbara Echiburú in
Google Scholar
PubMed
Search for other papers by Manuel Maliqueo in
Google Scholar
PubMed
Search for other papers by Marta Luchsinger in
Google Scholar
PubMed
Search for other papers by Pedro Rojas in
Google Scholar
PubMed
Search for other papers by Sergio Recabarren in
Google Scholar
PubMed
Search for other papers by Teresa Sir-Petermann in
Google Scholar
PubMed
groups ( 14 ). Regarding metabolic features, we observed increased weight from an early age and some indicators of insulin resistance during adulthood ( 12 ). Puberty is a transition period between childhood and adulthood accompanied by profound changes
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Pernille H Hellmann in
Google Scholar
PubMed
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Jonatan I Bagger in
Google Scholar
PubMed
Search for other papers by Katrine R Carlander in
Google Scholar
PubMed
Search for other papers by Katrine B Hansen in
Google Scholar
PubMed
Search for other papers by Julie L Forman in
Google Scholar
PubMed
Search for other papers by Joachim Størling in
Google Scholar
PubMed
Search for other papers by Elizaveta Chabanova in
Google Scholar
PubMed
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Jens Holst in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Search for other papers by Tina Vilsbøll in
Google Scholar
PubMed
Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Clinical Research, Steno Diabetes Center Copenhagen, Herlev, Denmark
Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark
Search for other papers by Filip K Knop in
Google Scholar
PubMed
that expression of 2% of our genome is regulated by glucocorticoids ( 5 ). Prednisolone is known to induce insulin resistance, increased hepatic glucose production, hyperglycaemia and secondary diabetes. Even lean, healthy individuals can experience
Search for other papers by Thozhukat Sathyapalan in
Google Scholar
PubMed
Search for other papers by Anne-Marie Coady in
Google Scholar
PubMed
Search for other papers by Eric S Kilpatrick in
Google Scholar
PubMed
Search for other papers by Stephen L Atkin in
Google Scholar
PubMed
reduction in insulin resistance especially with weight loss in patients with T2DM will result in normalisation of pancreatic β-cell requirement and even reversal of T2DM ( 9 ). Statins have shown to improve certain features of polycystic ovary syndrome
Search for other papers by Melinda Kertész in
Google Scholar
PubMed
Search for other papers by Szilárd Kun in
Google Scholar
PubMed
Search for other papers by Eszter Sélley in
Google Scholar
PubMed
Search for other papers by Zsuzsanna Nagy in
Google Scholar
PubMed
Search for other papers by Tamás Kőszegi in
Google Scholar
PubMed
Search for other papers by István Wittmann in
Google Scholar
PubMed
Introduction Insulin resistance related to glucotoxicity and lipotoxicity is a well-described phenomenon ( 1 , 2 ). It is also known that in insulin-resistant patients other hormonal resistance may occur (e.g. resistance to leptin and FSH ( 3
Search for other papers by Jia Liu in
Google Scholar
PubMed
Search for other papers by Lin Zhang in
Google Scholar
PubMed
Search for other papers by Jing Fu in
Google Scholar
PubMed
Search for other papers by Qiu Wang in
Google Scholar
PubMed
Search for other papers by Guang Wang in
Google Scholar
PubMed
increased insulin sensitivity and regulated glucose and lipid metabolism in rodent models ( 10 , 11 , 12 ). PRL receptor knockout caused insulin resistance and severe adipose tissue dysfunction in obese mice ( 10 ). Many population-based studies found that